Press Room

ALR Press Releases

New Study Findings Represent a Critical Step Forward for People with Lupus
November 2, 2009
Findings from the BLISS-76 Phase III clinical trial of BENLYSTA™ (belimumab) represent an important milestone in the development of new therapeutic options for patients with systemic lupus erythematosus. 

ALR In The News

Rookies Join Rex, Mike T, Fans in Lupus Walk
June 7, 2009
It would be hard to imagine a more spectacular Sunday morning for the Jets organization. Teaming up with the Alliance for Lupus Research for the seventh annual Northern New Jersey Walk With Us to Cure Lupus, the Jets had 1,200 people participate in the 5K (3.1-mile) stroll, which began and ended at their new home — the Atlantic Health Jets Training Center.

General Lupus News

Grant Boosts The Oklahoma Medical Research Foundation's Lupus Studies
August 14, 2009
The Oklahoma Medical Research Foundation has been awarded a $10 million grant from the National Institiute of Health to study the autoimmune disease lupus.

Human Interest

Waging war against life-threatening lupus
January 6, 2010
Karen Birney of Narrowsburg is certain there are times people notice her in her motorized scooter — and are convinced there's nothing wrong with her.

Click here to download a pdf version of this article.

Research In The News

Genomes of identical twins reveal epigenetic changes that may play role in lupus
December 22, 2009
Identical twins look the same and are nearly genetically identical, but environmental factors and the resulting cellular changes could cause disease in one sibling and not the other. In a study published online in Genome Research (www.genome.org), scientists have studied twins discordant for the autoimmune disease lupus, mapping DNA modifications across the genome and shedding light on epigenetic changes that may play a role in the disease.

Scientific Publications

The Peroxisome Proliferator-Activated Receptor Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus
July 20, 2009
Individuals with systemic lupus erythematosus (SLE) have a striking increase in the risk of premature atherosclerosis, a complication preceded by significant subclinical vascular damage.

Disclaimer

The links herein provide content that might be of interest to our visitors. We are not responsible for the material at other sites to which we have established links and establishing a link does not constitute an endorsement of that material.

The information displayed by the sites we link to is no substitute for expert medical care. We recommend that you discuss your condition and any information you may obtain about it with your physician.